Home Research Reports Demand for clean and advanced therapeutic measures to take the cancer arm of healthcare vertical to a greater stride

Demand for clean and advanced therapeutic measures to take the cancer arm of healthcare vertical to a greater stride

by Jackson B
Demand for clean and advanced therapeutic measures to take the cancer arm of healthcare vertical to a greater stride

 

The healthcare personnel have always been on toes as the world has witnessed outbreak of some or the other illnesses on continuous basis, though something like Covid-19 happens once in a century. These trying times have accelerated the need for cleanroom technology all over. Type-wise, the cleanroom technology market spans cleanroom equipment market and cleanroom consumables. Cleanroom equipment market is further classified into HVAC systems, FFU (fan filter units), biosafety cabinets and laminar sir flow systems, air diffusers, HEPAA filters, and showers. Amongst the safety consumables are gloves, apparel, and others. Cleaning consumables include wipes, vacuum systems, disinfectants, and others.

An exorbitant rise in chronic ailments is driving the demand for next-generation antibody therapeutics. Moreover, initially, these antibody-drug conjugates (ADCs) were confined to cancer, but Genentech has gone a step ahead with application of these ADCs to the infectious diseases, thereby resulting in TACs (Thiomab antibiotic conjugates) for treating methicillin-resistant Staphylococcus aureus, better known as MRSA. Technology-wise, next-generation antibody therapeutics market spans BsAbs (Bispecific Antibodies), ADCs, antibody-like proteins (AF & ALPs), Fc-engineered antibodies, biosimilar antibody (Ab) products, and others.

Early diagnosis is asked for with the influx of several diseases like SARS, Ebola, MERS, avian flu, chikungunya, Zika, swine flu, and the latest – Covid-19. As such, infectious disease diagnostics has picked up pace. POC diagnostic kits are in great demand. Technology-wise, the infectious disease diagnostics market comprises clinical microbiology, immunodiagnostics, polymerase chain reaction, isothermal nucleic acid amplification technology, DNA sequencing and NGS (Next-Generation Sequencing), DNA microarray technology, and others (hybridization, microscopy, and loop-mediated isothermal amplification).

Cryotherapy, better known as cryogenic therapy, comes across as a minimally invasive therapy that makes use of incredibly cold temperatures for destroying the diseased tissue. The ailments treated include arthritis, cancer, pain, and skin-oriented conditions such as dark spots, skin tags, and warts. The advantages of cryosurgery over conventional surgeries are inclusive of reduced stay at the hospital, smaller incisions, faster wound healing, reduced surgical wounds and pain, and lesser risk of the complications. By type of device, cryotherapy market comprises cryogun, cryo probes (tissue spray probes and tissue contact probes), gas cylinders, localized cryotherapy devices, and cryochambers & cryosaunas.

Europe cryochambers market, by type of product, says individual units/cryosuna (services, devices) and multiple person units/cryochamberss (services and devices). Application-wise, it’s dermatology and beauty aapplications, pain management and sports medicine, and others (rehabilitation, and health & wellness). Poland holds the distinction of being the market growing at the fastest rate in Europe cryochambers.

Increasing number of surgeries (esp. the complex ones) calls for minimally invasive means, which, in turn, calls for intraoperative imaging. Product-wise, it could be categorized into iUltrasound, iMRI, iCT, and C-arm Systems. Application-wise, it’s oncology surgery, ENT surgery, orthopaedic surgery, neurosurgery, trauma surgery/emergency room, cardiovascular, and others. Modern intraoperative imaging systems do make way for high-resolution, real-time images for enhancing the process of monitoring at the time of surgery. Resection rate could also be reduced herein.

Antibody library technology is in demand due to growing need for therapies for treating neurological disorders, rare diseases, and cancer. On the developments’ front, Medical University of South Carolina (MUSC) collaborated with CET (Cumberl and Emerging Technologies) for developing new-fangled biomedical products. On the similar grounds, Amicus Therapeutics, in October 2018, did enter research alliance with the University of Pennsylvania for developing new gene therapies. Also, WuXi, of late, came up with DNA Encoded Library (DEL) service package known as “DELight” for accelerating early drug discovery process. Besides, Creative Biolabs tabled a wide antibody design and conjugation service, thereby turning out to be one of the leading associations of the global clients all through custom ADCs.

Soft tissue repair is flourishing due to increase in the injuries related to soft tissues amongst the geriatric population. By product, it’s tissue patch/mesh (synthetic mesh and biological mesh (allograft and xenograft)) and fixation devices (suture anchors, interference screw, and other fixation devices), and laparoscopic instruments. Application-wise, it’s dural repair, hernia repair, skin repair, vaginal sling procedures, orthopaedic repair, dental repair, and breast reconstruction repair.

Immunotherapy is replacing conventional chemotherapy these days. By type, immune checkpoint inhibitors comprise PD-1 Inhibitor, CTLA-4 Inhibitor, PD-L1 Inhibitor, and others. Application-wise, it’s bladder cancer, lung cancer, melanoma, Hodgkin Lymphoma, and others. Out of these lung cancer holds the largest market share due to aftereffects of cigarette smoking. Also, the aging population tends to go weak on lungs.

Oral solid dosage contract manufacturing is witnessing an increasing demand due to quest for reducing costs all over. Along these lines, Lonza, in October 2020, did declare investment worth US$ 93 Mn in its CHI (Capsules and Heaalth Ingredients) division with the objective of increasing its overall capsule production capacity within Capsugel portfolio.

Persistence market Research (PMR) has profiled the key players as follows:

  • Royal Imtech
  • Ardmac Ltd.
  • Clean Air Products
  • ImmunoGen Inc.
  • Biogen
  • Pfizer Inc.
  • Danaher Corporation
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Meridian Bioscience Inc.
  • DiaSorin S.p.A.
  • Medtronic
  • Brymill Cryogenic Systems
  • Cryoalfa
  • Siemens Healthineers
  • Brainlab AG
  • Air Products and Chemicals, Inc.
  • KrioSystem Sp. z.o.o
  • XOMA Corporation
  • MorphoSys AG
  • Adimab LLC
  • Wright Medical Technology
  • Arthrex, Inc.
  • Organogenesis
  • Fortress Biotech, Inc.
  • Bristol-Myers Squibb Company
  • Piramal Enterprises Ltd.
  • Metrics Contract Services
  • Arnet Pharmaceuticals
  • Jubilant Life Sciences

You may also like